Global RNA Therapeutics Market, By Technology (RNA Interference, and Antisense RNA), By Route of Administration (Pulmonary Delivery, Intravenous Injections, Intra-dermal Injections, Topical Delivery and Others), By Indications (Oncology, CVDs, Respiratory Disorders, Neurological Disorders, Infectious Disorders and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI477321 | Publish Date: August 2023 | No. of Pages: 130

Global RNA Therapeutics Market Overview

RNA Therapeutics are a rapidly growing class of pharmaceuticals that will accelerate the development of new treatments, enable personalised therapy, and render the term "undruggable" obsolete. The first RNA medications have been approved, and a large number of others are in the works. We are in the midst of a therapeutic revolution unseen since the introduction of recombinant protein technology in Silicon Valley about 50 years ago. Recent improvements in the production, purification, and transport of RNA to cells have paved the way for the development of RNA-based therapies for a wide range of uses. RNA therapies are a rapidly growing class of medications that will revolutionize the treatment of numerous diseases and enable personalized therapy. These medications are inexpensive, easy to make, and can target routes that were previously unreachable. Small biotech businesses and university groups can quickly produce new and tailored RNA structures, making it a breakthrough medicinal tool. The Global RNA Therapeutics Market accounted for US$ 1.35 billion in 2020 and is estimated to be US$ 2.77 billion by 2030 and is anticipated to register a CAGR of 7.50%.

Global RNA Therapeutics Market Dynamics

Rising awareness and development of novel drugs

Multinational healthcare organizations raise awareness and assist in the development of novel remedies for a variety of ailments. Private institutes participating in conducting trials by supporting research institutes and pharmaceutical companies, such as the California Institute of Regenerative Medicine and the ALS Association, are predicted to considerably fuel sector expansion. Furthermore, government initiatives aimed at accelerating the development of medication delivery systems in order to lower illness burdens contribute to industrial development.

Antisense and RNAi therapies can be used to treat a variety of disorders that impact the cell growth cycle and target nucleic acids. The ability of miRNA to restore gene expression and correct protein production, consequently impacting industrial advancement, is receiving a lot of attention. Research into the use of various pathways to deliver the intended impact of the candidate moiety before it is removed from the blood is expected to boost sector expansion.

The constraints involved with drug distribution, on the other hand, are projected to hamper expansion to some extent.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global RNA Therapeutics Market Segmentation

 

                                            Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

The Global RNA Therapeutics Market is segmented based on technology, route of administration indication and region.

On the basis of Technology, the Global RNA Therapeutics Market is segmented into RNA Interference and Antisense RNA. Based on Route of administration, the target market is segmented into Pulmonary Delivery, Intravenous Injections, Intra-dermal Injections, Topical Delivery and Others. Based on Indication, the target market is segmented into Oncology, CVDs, Respiratory Disorders, Neurological Disorders, Infectious Disorders and Others.

Regional Insights:

On region the Global RNA Therapeutics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The RNA therapeutics market was dominated by North America, followed by Europe, Asia Pacific, Latin America, and the Middle East and Africa. The growing development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, high life science research funding, high biopharmaceutical R&D expenditure, and greater adoption of advanced technologies in North America can all be attributed to this market segment's large share. Another important reason contributing to this market segment's significant share is the presence of a large number of global companies in this area. North America now holds the largest revenue share of the market because much of the research and development work is centred in that region. However, over the forecast period, Asia Pacific and other growing regions would gradually catch up.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By technology- RNA Interference and Antisense RNA

By Route of Administration– Pulmonary Delivery, Intravenous Injections, Intra-dermal Injections, Topical Delivery and Others

By Indication- Oncology, CVDs, Respiratory Disorders, Neurological Disorders, Infectious Disorders and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global RNA Therapeutics Market report based on technology, route of administration, indication and region.

 

                                       

Global RNA Therapeutics Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global RNA Therapeutics Market Key Players

Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US). Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.

Global RNA Therapeutics Market Company Profile

  • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Agilent Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Illumina, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • QIAGEN N.V.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Danaher Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Global RNA Therapeutics Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for RNA Therapeutics Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Technology
      • Market Snippet, By Route of Administration
      • Market Snippet, By Indication
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global RNA Therapeutics Market, By Technology, 2020 – 2030, (US$ Bn)
    • Overview              
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • RNA Interference
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Antisense RNA
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global RNA Therapeutics Market, By Route of Administration, 2020 – 2030, (US$ Bn)
    • Overview                                
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Pulmonary Delivery
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Intravenous Injections
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Intra-dermal Injections
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Topical Delivery
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global RNA Therapeutics Market, By Indication, 2020 – 2030, (US$ Bn)
    • Overview                               
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Oncology
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • CVDs
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Respiratory Disorders
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Neurological Disorders
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Infectious Disorders
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global RNA Therapeutics Market, By Region, 2020 – 2030, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Bn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Indication, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
  • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Agilent Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Illumina, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • QIAGEN N.V.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Danaher Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The Global RNA Therapeutics Market is segmented based on technology, route of administration, indication and region.

Rising awareness and development of novel drugsis the major factor driving growth of the global market

The RNA therapeutics market was dominated by North America, followed by Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US).